Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Microprofit Biotech is a high-tech enterprise specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and instruments. Founded in 2009 and headquartered in Shenzhen, China, the company focuses on Point-of-Care Testing (POCT) solutions through its proprietary fluorecare platform. Their product portfolio includes a wide range of rapid diagnostic tests for cardiovascular diseases, infectious diseases, diabetes, and inflammatory markers. Microprofit Biotech operates with international quality standards, including ISO 13485 and CE certifications, serving healthcare providers globally. The company gained significant international recognition for its rapid antigen testing solutions during the COVID-19 pandemic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Microprofit Biotech.